Revitalize Energizing Eye Drops Liquid
NDC Package 82864-001-01
Package Information
Revitalize Energizing Eye Drops (naphazoline hydrochloride , propylene glycol) liquids is put 1 or 2 drops in the affected eye(s) up to 4 times daily Tightly screw on cap to seal after use. This formulation utilizes a liquid delivery system. Marketed by Revitalize Energy Inc., this product is identified by NDC 82864-001 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 2627786 - naphazoline hydrochloride 0.03 % / propylene glycol 1 % Ophthalmic Solution
- RxCUI: 2627786 - naphazoline hydrochloride 0.3 MG/ML / propylene glycol 10 MG/ML Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82864 - Revitalize Energy Inc.
- 82864-001 - Revitalize Energizing Eye Drops
- 82864-001-01 - 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER
- 82864-001 - Revitalize Energizing Eye Drops
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (82864-001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82864-001-01 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 15 ml in 1 bottle, dropper of Revitalize Energizing Eye Drops, a human over the counter drug labeled by Revitalize Energy Inc.. This liquid is formulated for ophthalmic use and contains naphazoline hydrochloride; propylene glycol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Revitalize Energy Inc. on February 01, 2023. The current certification is valid through December 31, 2026.
How is this Revitalize Energy Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82864000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.